Advertisement

Organisation › Details
Euronext (Group)
Euronext is the leading pan-European exchange in the Eurozone with nearly 1,300 listed issuers worth close to €3.6 trillion in market capitalisation as of end December 2017, an unmatched blue chip franchise consisting of 24 issuers in the Morningstar® Eurozone 50 Index? and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, Euronext also operates Euronext GrowthTM (formerly known as Alternext) and Euronext AccessTM (formerly known as the Free Market). *
![]() |
Industry | financial services |
![]() |
Person | Boujnah, Stéphane (Euronext 201711 CEO) |
![]() |
Region | Amsterdam |
Country | Netherlands | |
Street | 5 Beursplein | |
City | n. a. Amsterdam | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | EUR | |
Annual sales | 532,300,000 (revenue, consolidated (2017) 2017-12-31) | |
Profit | 241,300,000 (2017-12-31) | |
Cash | 187,800,000 (2017-12-31) | |
* Document for �About Section�: Euronext N.V.. (2/19/18). "Press Release: Euronext Publishes Full Year 2017 Results". Amsterdam, Brussels, et al.. | ||
Record changed: 2020-12-11 |
Advertisement

More documents for Euronext (Group)
- [1] Hyloris Pharmaceuticals S.A.. (6/17/20). "Press Release: Hyloris Pharmaceuticals Launches Its Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège....
- [2] Hyloris Pharmaceuticals S.A.. (6/3/20). "Press Release: Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussels [Not for US, AU, CA, CH, IL, JP or ZA]". Liège....
- [3] Valneva S.E.. (12/20/19). "Press Release: Valneva Completes Delisting from the Vienna Stock Exchange". Saint-Herblain....
- [4] ImmuPharma plc. (12/19/19). "Press Release: ImmuPharma Lists on Euronext Growth Brussels". Brussels....
- [5] Themis Bioscience N.V.. (11/8/18). "Press Release: Themis Bioscience Postpones Its Listing on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna....
- [6] Themis Bioscience N.V.. (10/29/18). "Press Release: Themis Bioscience Launches its Initial Public Offering on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna....
- [7] Euronext N.V.. (10/8/18). "Press Release: Medincell Lists on Euronext Paris. €30 Million Raised, Market Capitalisation €144 Million". Paris....
- [8] Euronext N.V.. (5/30/18). "Press Release: Digital Biotech Voluntis Lists on Euronext". Paris....
- [9] Euronext N.V.. (3/5/18). "Press Release: Acacia Pharma Lists on Euronext Brussels". Brussels....
- [10] Acacia Pharma Group Ltd.. (3/2/18). "Press Release: Acacia Pharma Successfully Prices Initial Global Offering at EUR 3.60 per Share Raising EUR40m [Not for US, AU, CA, JP, ZA, et al.]". Cambridge & Indianapolis, IN....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement
![Picture [iito] Back into Ad 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-back-into-ad.jpg)
» top